Search

MSK's Robert Motzer presented positive data from a phase III randomized study that assessed two different treatment combinations as first-line therapies that may benefit people with advanced kidney cancer.

… Monday, February 15, 2021 Update: On August 11, 2021, the FDA approved pembrolizumab (Keytruda®) plus lenvatinib (Lenvima®) for first-line treatments for patients with advanced renal cell carcinoma (RCC). Memorial Sloan Kettering Cancer Center (MSK) physicians and scientists presented new research at

Pediatric oncologists from around the world will gather in Lyon, France, from October 23 through 26, for the International Society of Paediatric Oncology’s annual meeting. Featuring new research and important discoveries — many led by MSK Kids researchers — the meeting will highlight the latest in the fields of pediatric oncology, including blood cancer, sarcoma, Wilms’ tumor, genomics, radiation oncology, and neuroblastoma.

… Tuesday, October 22, 2019 Pediatric oncologists from around the world will gather in Lyon, France, from October 23 through 26, for the International Society of Paediatric Oncology’s annual meeting. Featuring new research and important discoveries — many led by MSK Kids researchers — the meeting will

Positive results from a clinical trial published in The New England Journal of Medicine show that the combination of the immunotherapy drugs ipilimumab (Yervoy™) and nivolumab (Opdivo™), produced significantly better outcomes than ipilimumab alone in patients with advanced melanoma. A second piece in the same issue from MSK details a dramatic response occurring after a single dose of the combination therapy.

… Monday, April 20, 2015 Researchers from Memorial Sloan Kettering Cancer Center (MSK) are reporting exciting results in the field of cancer immunology. Positive results from a clinical trial published today in The New England Journal of Medicine show that the combination of the immunotherapy drugs ipilimumab

Learn about a clinical trial at Memorial Sloan Kettering that gives people with rectal cancer a new option to be treated without radiation. The research shows that a well-known chemotherapy regimen used alone can be just as effective as chemotherapy given with radiation before surgery. The new method may reduce side effects associated with radiation such as loss of fertility and impaired bladder and sexual function.

… Sunday, June 4, 2023 Even a successful treatment can be improved, to give patients more options, including fewer side effects. That is the benefit of an important clinical trial (research study) involving rectal cancer treatment without radiation that was announced in early June at the American Society

Conozca un ensayo clínico en Memorial Sloan Kettering que ofrece a las personas con cáncer de recto una nueva opción de tratamiento sin radiación. La investigación muestra que un régimen de quimioterapia conocido, usado solo, puede ser tan eficaz como la quimioterapia combinada con radiación antes de la cirugía. El nuevo método puede reducir los efectos secundarios de la radiación, como la pérdida de fertilidad y los problemas en la función de la vejiga y la función sexual.

… Sunday, June 4, 2023 Hasta un tratamiento exitoso se puede mejorar para dar a los pacientes más opciones, incluso menos efectos secundarios. Ese es el beneficio de un importante ensayo clínico (estudio de investigación) que involucra el tratamiento contra el cáncer de recto sin radiación y que se anunció

Two outstanding graduate students from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences (GSK) have been awarded federal funding to pursue promising cancer research.

… Friday, June 28, 2019 Summary Yuchen Xie and Miguel Miranda-Roman, two GSK students, have been awarded prestigious federal funding. Two outstanding graduate students from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences (GSK) have been awarded federal funding to pursue promising cancer

Almost everyone gets medical information online, but it can be hard to know what's true. In this story, MSK provides tips for evaluating online content.

… Thursday, March 12, 2026 These days, nearly everyone gets medical information online , especially through  social media . Some of this information can be helpful, but much of it is false or misleading — and potentially dangerous.   With the flood of medical content readily available on our phones and

The National Academy of Medicine (NAM) has named Hedvig Hricak, MD, PhD, Chair of the Department of Radiology, a recipient of the David Rall Medal. The medal is given annually to a NAM member who has demonstrated outstanding leadership. Dr. Hricak received the award at the 2018 NAM Annual Meeting on Monday, October 15, 2018, in Washington, D.C.

… Monday, October 15, 2018 The National Academy of Medicine (NAM) has named Hedvig Hricak, MD, PhD , Chair of the Department of Radiology, a recipient of the David Rall Meda l . The medal is given annually to a NAM member who has demonstrated outstanding leadership. Dr. Hricak will receive the award at

Luis Alberto Diaz, Jr. has dedicated his life’s work to addressing some of the most pressing challenges in cancer research — driven by one clear aim.

… Friday, January 1, 2021 Luis Alberto Diaz, Jr. , has dedicated his life’s work to addressing some of the most pressing challenges in cancer research — driven by one clear aim. “When I entered medicine, there were many beautiful areas of study that offered opportunities to explore unknown questions, like

Read about advances in lung cancer treatment presented by MSK scientists at the 2024 ASCO meeting.

… Monday, June 3, 2024 Researchers from Memorial Sloan Kettering Cancer Center (MSK) reported important advances in the treatment of lung cancer at the June 2024 annual meeting of the American Society of Clinical Oncology (ASCO). Scientists presented promising results from two clinical trials that are